Log in to save to my catalogue

Hormone Receptors and Epithelial Ovarian Cancer: Recent Advances in Biology and Treatment Options

Hormone Receptors and Epithelial Ovarian Cancer: Recent Advances in Biology and Treatment Options

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9fb960821c224003add3afa2bf05125a

Hormone Receptors and Epithelial Ovarian Cancer: Recent Advances in Biology and Treatment Options

About this item

Full title

Hormone Receptors and Epithelial Ovarian Cancer: Recent Advances in Biology and Treatment Options

Publisher

Basel: MDPI AG

Journal title

Biomedicines, 2023-08, Vol.11 (8), p.2157

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Epithelial ovarian cancer (EOC) is a significant cause of cancer-related mortality in women. Despite advances in diagnosis and treatment, EOC remains a challenging disease to manage, and the 5-year survival rate is still poor. The role of hormone receptors (HRs) in EOC carcinogenesis and prognosis has been actively explored; however, the role of ho...

Alternative Titles

Full title

Hormone Receptors and Epithelial Ovarian Cancer: Recent Advances in Biology and Treatment Options

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9fb960821c224003add3afa2bf05125a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9fb960821c224003add3afa2bf05125a

Other Identifiers

ISSN

2227-9059

E-ISSN

2227-9059

DOI

10.3390/biomedicines11082157

How to access this item